AVT Natural Products Ltd
AVT Natural Products Limited is a part of the A.V. Thomas Group. The Company is engaged in the business of manufacturing plant-based extracts and natural ingredients solutions for the food, beverage, animal nutrition and nutraceutical industries of the world. [1]
- Market Cap ₹ 1,279 Cr.
- Current Price ₹ 84.0
- High / Low ₹ 116 / 76.9
- Stock P/E 26.3
- Book Value ₹ 29.3
- Dividend Yield 1.19 %
- ROCE 24.7 %
- ROE 17.9 %
- Face Value ₹ 1.00
Pros
- Company has delivered good profit growth of 29.6% CAGR over last 5 years
- Company has been maintaining a healthy dividend payout of 22.3%
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: FMCG Industry: Food - Processing - Indian
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
218 | 256 | 271 | 257 | 267 | 307 | 300 | 330 | 385 | 470 | 542 | 582 | 513 | |
134 | 171 | 192 | 207 | 227 | 263 | 270 | 289 | 325 | 402 | 439 | 465 | 436 | |
Operating Profit | 84 | 85 | 79 | 50 | 41 | 44 | 30 | 41 | 60 | 69 | 103 | 117 | 77 |
OPM % | 38% | 33% | 29% | 20% | 15% | 14% | 10% | 12% | 15% | 15% | 19% | 20% | 15% |
1 | 0 | 4 | 3 | 1 | 6 | 12 | 4 | 7 | 7 | 9 | 2 | 7 | |
Interest | 6 | 6 | 2 | 3 | 1 | 1 | 2 | 4 | 4 | 3 | 3 | 4 | 5 |
Depreciation | 3 | 4 | 5 | 6 | 6 | 7 | 7 | 11 | 14 | 15 | 14 | 13 | 14 |
Profit before tax | 75 | 76 | 76 | 44 | 35 | 42 | 33 | 30 | 49 | 58 | 94 | 102 | 66 |
Tax % | 33% | 33% | 33% | 32% | 33% | 33% | 35% | 30% | 22% | 26% | 25% | 27% | |
50 | 51 | 51 | 30 | 23 | 28 | 21 | 21 | 38 | 42 | 71 | 75 | 49 | |
EPS in Rs | 3.32 | 3.33 | 3.35 | 1.98 | 1.53 | 1.83 | 1.40 | 1.39 | 2.48 | 2.79 | 4.64 | 4.93 | 3.19 |
Dividend Payout % | 19% | 19% | 22% | 25% | 26% | 22% | 28% | 29% | 24% | 25% | 22% | 20% |
Compounded Sales Growth | |
---|---|
10 Years: | 9% |
5 Years: | 14% |
3 Years: | 15% |
TTM: | -11% |
Compounded Profit Growth | |
---|---|
10 Years: | 4% |
5 Years: | 30% |
3 Years: | 25% |
TTM: | -24% |
Stock Price CAGR | |
---|---|
10 Years: | 15% |
5 Years: | 26% |
3 Years: | 24% |
1 Year: | 5% |
Return on Equity | |
---|---|
10 Years: | 15% |
5 Years: | 15% |
3 Years: | 17% |
Last Year: | 18% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 8 | 8 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 |
Reserves | 88 | 127 | 158 | 178 | 194 | 220 | 233 | 246 | 273 | 307 | 365 | 425 | 431 |
31 | 26 | 0 | 0 | 0 | 0 | 23 | 65 | 25 | 37 | 11 | 15 | 44 | |
54 | 52 | 64 | 42 | 37 | 35 | 58 | 49 | 57 | 63 | 55 | 58 | 120 | |
Total Liabilities | 181 | 213 | 237 | 236 | 246 | 271 | 329 | 376 | 370 | 422 | 446 | 513 | 611 |
38 | 44 | 50 | 53 | 58 | 57 | 56 | 98 | 99 | 89 | 82 | 78 | 76 | |
CWIP | 0 | 3 | 0 | 2 | 1 | 0 | 28 | 0 | 0 | 0 | 2 | 0 | 2 |
Investments | 3 | 5 | 23 | 16 | 37 | 47 | 40 | 17 | 17 | 24 | 45 | 75 | 123 |
140 | 162 | 164 | 166 | 150 | 166 | 205 | 261 | 254 | 309 | 317 | 359 | 410 | |
Total Assets | 181 | 213 | 237 | 236 | 246 | 271 | 329 | 376 | 370 | 422 | 446 | 513 | 611 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
43 | 32 | 66 | 14 | 38 | 20 | 13 | -27 | 72 | 6 | 69 | 53 | |
-4 | -15 | -22 | -1 | -32 | -10 | -29 | 4 | -14 | -11 | -29 | -37 | |
-37 | -19 | -37 | -14 | -9 | -8 | 14 | 26 | -53 | -1 | -42 | -15 | |
Net Cash Flow | 1 | -2 | 7 | -1 | -3 | 2 | -1 | 2 | 5 | -6 | -1 | 1 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 61 | 55 | 53 | 61 | 64 | 74 | 78 | 80 | 69 | 86 | 71 | 81 |
Inventory Days | 344 | 296 | 267 | 271 | 185 | 178 | 197 | 335 | 232 | 239 | 257 | 299 |
Days Payable | 66 | 38 | 67 | 33 | 22 | 39 | 83 | 69 | 44 | 62 | 48 | 47 |
Cash Conversion Cycle | 339 | 313 | 253 | 299 | 227 | 213 | 192 | 346 | 257 | 263 | 280 | 333 |
Working Capital Days | 135 | 155 | 125 | 167 | 151 | 148 | 159 | 224 | 171 | 187 | 174 | 185 |
ROCE % | 70% | 57% | 47% | 26% | 17% | 18% | 13% | 11% | 16% | 18% | 26% | 25% |
Documents
Announcements
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 2d
- Closure of Trading Window 2d
-
Board Meeting Outcome for Revised Outcome
16 Feb - Outcome of Board Meeting held on 14.02.2024 being revised to include the date of commencement of Board meeting. Other items remain unchanged.
- Record Date For The Purpose Of Interim Dividend 2023-24 14 Feb
- Unaudited Financial Results For The Quarter Ended 31.12.2023 14 Feb
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from nse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2011
from nse
Products
The main products of the Co. are - Marigold Extracts for Eye Care, Food Coloring & Poultry Pigmentation; Spice oleoresin and Oils for Food Coloring and Flavoring; Value added Teas - Decaffeinated Teas and Instant Teas; Animal Nutrition Products; and Rosemary extract. [1]